ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE
Clinical trials for ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested to help dialysis patients fight anemia
Disease control CompletedThis study tested if a new drug called MT-6548 works as well as a standard treatment (darbepoetin alfa) for anemia in people with chronic kidney disease who are on dialysis. It involved 323 participants in Japan who were already receiving treatment for their anemia. The main goal…
Matched conditions: ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug tested to fight anemia in dialysis patients
Disease control CompletedThis study tested a drug called MT-6548 for people on kidney dialysis who have anemia (low red blood cells). The goal was to see if the drug could safely raise and keep hemoglobin levels in a healthy range. It involved 24 participants in Japan who were not using other common anem…
Matched conditions: ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC